In the present study we have evaluated 355 single nucleotide polymorphisms (SNPs) in 34 genes involved in tau modification or metabolism for association with CSF levels of ptau181, then determined the effects of those variants on AD risk, onset and rate of progression. Here, MAPT is linked to Alzheimer disease.